In recent years, the Chinese government has introduced a series of policies to encourage drug development and innovation, more and more local companies are trying to step into this hot area. Especially in the field of biopharmaceuticals, China has now become the second largest base for innovative drug development in the world. In this context, the selection of therapeutic areas and targets at the early stage of innovative drug development has also become more important.
To help companies who are interested in China’s innovative drug market better know the development trends and competition. Mr. Hong Liang, general manager of Ruiou BaiPharm, will give a brief introduction and analysis of the popular fields and target points of innovative drugs in China in this webinar.
